This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
3446 CTNNB1 mutation status correlates with progression arrest in RECIST progressive desmoid tumors treated with imatinib - results from the phase II study of the German Interdisciplinary Sarcoma Group (GISG-01). (September 2015)
Record Type:
Journal Article
Title:
3446 CTNNB1 mutation status correlates with progression arrest in RECIST progressive desmoid tumors treated with imatinib - results from the phase II study of the German Interdisciplinary Sarcoma Group (GISG-01). (September 2015)
Main Title:
3446 CTNNB1 mutation status correlates with progression arrest in RECIST progressive desmoid tumors treated with imatinib - results from the phase II study of the German Interdisciplinary Sarcoma Group (GISG-01)